Evidence map›Paper›PMID 28900478›Full record

ArticleJournal of Cancer2017

Esophageal Cancer in Israel has Unique Clinico-Pathological Features: A Retrospective Study.

Michal Sarfaty, Esty Lankry, Assaf Moore, Noga Kurman, Ofer Purim, Yulia Kundel, Irit Ben-Aharon, Gali Perl, Olga Ulitsky, Noa Gordon and 4 more

Open access · goldAbstract read
In one paragraph

Article in Journal of Cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 85% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Thoracic surgery in Israel.Journal of thoracic disease · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Michal SarfatyInstitute of Oncology, Davidoff Center, Rabin Medical Center, Petach Tikva, Israel.
Esty LankrySackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel.
Assaf MooreInstitute of Oncology, Davidoff Center, Rabin Medical Center, Petach Tikva, Israel.
Noga KurmanInstitute of Oncology, Davidoff Center, Rabin Medical Center, Petach Tikva, Israel.
Ofer PurimInstitute of Oncology, Davidoff Center, Rabin Medical Center, Petach Tikva, Israel.
Yulia KundelInstitute of Oncology, Davidoff Center, Rabin Medical Center, Petach Tikva, Israel.
Irit Ben-AharonInstitute of Oncology, Davidoff Center, Rabin Medical Center, Petach Tikva, Israel.
Gali PerlInstitute of Oncology, Davidoff Center, Rabin Medical Center, Petach Tikva, Israel.
Olga UlitskyInstitute of Oncology, Davidoff Center, Rabin Medical Center, Petach Tikva, Israel.
Noa GordonInstitute of Oncology, Davidoff Center, Rabin Medical Center, Petach Tikva, Israel.
Aaron SulkesInstitute of Oncology, Davidoff Center, Rabin Medical Center, Petach Tikva, Israel.
Nikolai MenasherovDepartment of Surgery A, Rabin Medical Center, Petach Tikva, Israel.
Hanoch KashtanDepartment of Surgery B, Rabin Medical Center, Petach Tikva, Israel.
Baruch BrennerInstitute of Oncology, Davidoff Center, Rabin Medical Center, Petach Tikva, Israel.
Rabin Medical Center · ILTel Aviv University · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdenocarcinomaEpidemiologyEsophageal cancerIsraelSquamous

Identifiers

PMID28900478
PMCPMC5595070
OpenAlexW2740908016

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.